- Clinical Professor, Global Health
- Clinical Professor, Medicine - Allergy and Infectious Dis.
- Interim President and Chief Executive Officer, Infectious Disease Research Institute
Select from the following:
Corey Casper is the Interim President and Chief Executive Officer at the Infectious Disease Research Institute in Seattle. He also serves as an Affiliate Member at the Fred Hutchinson Cancer Research Center.
Dr. Casper received his medical degree from Cornell University, and completed a residency in Internal Medicine at the University of California – San Francisco and a fellowship in Infectious Disease at the University of Washington, where he also earned a Masters of Public Health. His research focuses on the relationship between infectious diseases, immunity and cancer. He has authored more than 120 peer-reviewed publications, and serves on several international advisory boards.
At IDRI, Dr. Casper oversees a scientific portfolio of vaccines, therapeutics, and diagnostics that together provide comprehensive solutions to global health problems. These include vaccines, drugs and diagnostics to reduce the burden of tuberculosis around the globe, the first vaccine specifically designed to prevent and treat leprosy, and the development of a novel RNA replicon platform for the prevention of pandemic / emerging viruses and the treatment of cancer.
- MD (Cornell University)
- MPH (University of Washington)
- Biodefense Infectious Diseases
- Business and Public Private Partnerships
- Cervical Cancer
- HIV Transmission
- Host-Pathogen Interactions
- Infectious Diseases
- Infectious Diseases (other than STDs)
- Neglected Diseases, Tropical Medicine (incl. Parasites)
- Non-Communicable Diseases
- STDs (other than HIV)
van Rhee F, Wong RS, Munshi N, Rossi JF, Ke XY, Fossa A, Simpson D, Capra M, Liu T, Hsieh RK, Goh YT, Zhu J, Cho SG, Ren H, Cavet J, Bandekar R, Rothman M, Puchalski TA, Reddy M, van de Velde H, Vermeulen J, Casper C. Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial. Lancet Oncol. 2014;15(9):966-74. doi: 10.1016/S1470-2045(14)70319-5. PubMed PMID: 25042199.
Gantt S, Orem J, Krantz EM, Morrow RA, Selke S, Huang ML, Schiffer JT, Jerome KR, Nakaganda A, Wald A, Corey L+, Casper C+ Prospective Characterization of the Risk Factors for Transmission and Symptoms of Primary Human Herpesvirus Infections Among Ugandan Infants. J Infect Dis. 2016;214(1):36-44. doi: 10.1093/infdis/jiw076. PubMed PMID: 26917575; PMCID: PMC4907408.
Grande, B. M., Gerhard, D. S., Jiang, A., Griner, N. B., Abramson, J. S., Alexander, T. B., Allen, H., Ayers, L. W., Bethony, J. M., Bhatia, K., Bowen, J., Casper, C., Choi, J. K., Culibrk, L., Davidsen, T. M., Dyer, M. A., Gastier-Foster, J. M., Gesuwan, P., Greiner, T. C., Gross, T. G., Hanf, B., Harris, N. L., He, Y., Irvin, J. D., Jaffe, E. S., Jones, S. J., Kerchan, P., Knoetze, N., Leal, F. E., Lichtenberg, T. M., Ma, Y., Martin, J. P., Martin, M., Mbulaiteye, S. M., Mullighan, C. G., Mungall, A. J., Namirembe, C., Novik, K., Noy, A., Ogwang, M. D., Omoding, A., Orem, J., Reynolds, S. J., Rushton, C. K., Sandlund, J. T., Schmitz, R., Taylor, C., Wilson, W. H., Wright, G. W., Zhao, E. Y., Marra, M. A., Morin, R. D., & Staudt, L. M. (2019). Genome-wide discovery of somatic coding and non-coding mutations in pediatric endemic and sporadic Burkitt lymphoma. Blood, (), blood-2018-09-871418. Accessed January 17, 2019. https://doi.org/10.1182/blood-2018-09-871418.